HIGHLIGHTS
- who: Gent D.G. and colleagues from the Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Department of Clinical Medicine, Aalborg University, Aalborg, Denmark have published the Article: Trabectedin Cardiotoxicity in Soft Tissue Sarcoma: A Case Series and Clinical Insights, in the Journal: (JOURNAL)
- what: Only one other case had documented symptomatic improvement after stopping trabectedin , and here, the authors report an improvement in LVEF in 1 patient who stopped trabectedin and another who continued.
- future: Future work should focus on the underlying mechanism of cardiotoxicity the utility of treatment stratification . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.